Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the Elderly

<b>Introduction:</b> Osteoporosis is increasingly prevalent in the elderly, with fractures mostly occurring in women and men who are older than 55 and 65 years of age, respectively. The aim of this review was to examine the evidence regarding the influence of hormones on bone metabolism,...

Full description

Bibliographic Details
Main Authors: Rossella Cannarella, Federica Barbagallo, Rosita A. Condorelli, Antonio Aversa, Sandro La Vignera, Aldo E. Calogero
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Journal of Clinical Medicine
Subjects:
fsh
Online Access:https://www.mdpi.com/2077-0383/8/10/1564
id doaj-6bda8e8004ac444ab90da1c69238939e
record_format Article
spelling doaj-6bda8e8004ac444ab90da1c69238939e2020-11-25T01:33:26ZengMDPI AGJournal of Clinical Medicine2077-03832019-10-01810156410.3390/jcm8101564jcm8101564Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the ElderlyRossella Cannarella0Federica Barbagallo1Rosita A. Condorelli2Antonio Aversa3Sandro La Vignera4Aldo E. Calogero5Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, ItalyDepartment of Clinical and Experimental Medicine, University of Catania, 95123 Catania, ItalyDepartment of Clinical and Experimental Medicine, University of Catania, 95123 Catania, ItalyDepartment of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, 88100 Catanzaro, ItalyDepartment of Clinical and Experimental Medicine, University of Catania, 95123 Catania, ItalyDepartment of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy<b>Introduction:</b> Osteoporosis is increasingly prevalent in the elderly, with fractures mostly occurring in women and men who are older than 55 and 65 years of age, respectively. The aim of this review was to examine the evidence regarding the influence of hormones on bone metabolism, followed by clinical data of hormonal changes in the elderly, in the attempt to provide possible poorly explored diagnostic and therapeutic candidate targets for the management of primary osteoporosis in the aging population. <b>Material and methods:</b> An extensive Medline search using PubMed, Embase, and Cochrane Library was performed. <b>Results:</b> While the rise in Thyroid-stimulating hormone (TSH) levels has a protective role on bone mass, the decline of estrogen, testosterone, Insulin-like growth factor 1 (IGF1), and vitamin D and the rise of cortisol, parathyroid hormone, and follicle-stimulating hormone (FSH) favor bone loss in the elderly. Particularly, the AA rs6166 FSH receptor (FSHR) genotype, encoding for a more sensitive FSHR than that encoded by the GG one, is associated with low total body mass density (BMD), independently of circulating estrogen. A polyclonal antibody with a FSHR-binding sequence against the &#946;-subunit of murine FSH seems to be effective in ameliorating bone loss in ovariectomized mice. <b>Conclusions:</b> A complete hormonal assessment should be completed for both women and men during bone loss evaluation. Novel possible diagnostic and therapeutic tools might be developed for the management of male and female osteoporosis.https://www.mdpi.com/2077-0383/8/10/1564osteoporosisbone mineral densityfshtestosteronecortisoligf1vitamin d
collection DOAJ
language English
format Article
sources DOAJ
author Rossella Cannarella
Federica Barbagallo
Rosita A. Condorelli
Antonio Aversa
Sandro La Vignera
Aldo E. Calogero
spellingShingle Rossella Cannarella
Federica Barbagallo
Rosita A. Condorelli
Antonio Aversa
Sandro La Vignera
Aldo E. Calogero
Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the Elderly
Journal of Clinical Medicine
osteoporosis
bone mineral density
fsh
testosterone
cortisol
igf1
vitamin d
author_facet Rossella Cannarella
Federica Barbagallo
Rosita A. Condorelli
Antonio Aversa
Sandro La Vignera
Aldo E. Calogero
author_sort Rossella Cannarella
title Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the Elderly
title_short Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the Elderly
title_full Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the Elderly
title_fullStr Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the Elderly
title_full_unstemmed Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the Elderly
title_sort osteoporosis from an endocrine perspective: the role of hormonal changes in the elderly
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2019-10-01
description <b>Introduction:</b> Osteoporosis is increasingly prevalent in the elderly, with fractures mostly occurring in women and men who are older than 55 and 65 years of age, respectively. The aim of this review was to examine the evidence regarding the influence of hormones on bone metabolism, followed by clinical data of hormonal changes in the elderly, in the attempt to provide possible poorly explored diagnostic and therapeutic candidate targets for the management of primary osteoporosis in the aging population. <b>Material and methods:</b> An extensive Medline search using PubMed, Embase, and Cochrane Library was performed. <b>Results:</b> While the rise in Thyroid-stimulating hormone (TSH) levels has a protective role on bone mass, the decline of estrogen, testosterone, Insulin-like growth factor 1 (IGF1), and vitamin D and the rise of cortisol, parathyroid hormone, and follicle-stimulating hormone (FSH) favor bone loss in the elderly. Particularly, the AA rs6166 FSH receptor (FSHR) genotype, encoding for a more sensitive FSHR than that encoded by the GG one, is associated with low total body mass density (BMD), independently of circulating estrogen. A polyclonal antibody with a FSHR-binding sequence against the &#946;-subunit of murine FSH seems to be effective in ameliorating bone loss in ovariectomized mice. <b>Conclusions:</b> A complete hormonal assessment should be completed for both women and men during bone loss evaluation. Novel possible diagnostic and therapeutic tools might be developed for the management of male and female osteoporosis.
topic osteoporosis
bone mineral density
fsh
testosterone
cortisol
igf1
vitamin d
url https://www.mdpi.com/2077-0383/8/10/1564
work_keys_str_mv AT rossellacannarella osteoporosisfromanendocrineperspectivetheroleofhormonalchangesintheelderly
AT federicabarbagallo osteoporosisfromanendocrineperspectivetheroleofhormonalchangesintheelderly
AT rositaacondorelli osteoporosisfromanendocrineperspectivetheroleofhormonalchangesintheelderly
AT antonioaversa osteoporosisfromanendocrineperspectivetheroleofhormonalchangesintheelderly
AT sandrolavignera osteoporosisfromanendocrineperspectivetheroleofhormonalchangesintheelderly
AT aldoecalogero osteoporosisfromanendocrineperspectivetheroleofhormonalchangesintheelderly
_version_ 1725077242185252864